Omnicell, Inc. (OMCL)

Market Cap	1.34B
Revenue (ttm)	1.14B
Net Income (ttm)	21.18M
Shares Out	46.84M
EPS (ttm)	0.45
PE Ratio	63.34
Forward PE	21.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	255,198
Open	29.12
Previous Close	29.77
Day's Range	28.70 - 29.30
52-Week Range	22.66 - 55.75
Beta	0.76
Analysts	Buy
Price Target	44.83 (+56.15%)
Earnings Date	Jul 31, 2025

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy disp...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,670
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL
• Website: https://www.omnicell.com

Analyst Summary

According to 6 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price target is $44.83, which is an increase of 56.15% from the latest price.

Price Target

$44.83

(56.15% upside)

Analyst Consensus: Buy